A 48-year-old man with alcohol dependence is admitted with severe tremor, hallucinations (visual and tactile), autonomic instability (HR 130/min, BP 160/100 mmHg), and fever (38.2°C). He had his last drink 36 hours ago. Serum electrolytes, glucose, and liver function are deranged. What is the most appropriate immediate next step?

Explanation

## Clinical Diagnosis: Delirium Tremens (Alcohol Hallucinosis) This patient has **delirium tremens (DTs)**, the most severe form of alcohol withdrawal syndrome. The constellation of hallucinations, autonomic hyperactivity (tachycardia, hypertension, fever), tremor, and disorientation 36 hours post-cessation is pathognomonic. **Key Point:** Delirium tremens is a medical emergency with mortality up to 5% if untreated. It requires aggressive benzodiazepine therapy, supportive care, and correction of metabolic derangements. ## Management Algorithm for Delirium Tremens ```mermaid flowchart TD A["Delirium Tremens<br/>(hallucinations + autonomic hyperactivity)"]:::outcome --> B["Aggressive Benzodiazepine Dosing"]:::action B --> C["Lorazepam 4 mg IV<br/>repeat every 2–3 min<br/>until calm & seizure threshold raised"]:::action A --> D["Concurrent Supportive Care"]:::action D --> E["Thiamine 100 mg IV daily × 3 days<br/>Correct K+, Mg2+, glucose<br/>Monitor vitals & mental status"]:::action C --> F{"Seizure-free & stable?"}:::decision F -->|Yes| G["Maintenance: 1–2 mg lorazepam<br/>every 4–6 hours"]:::action F -->|No| H["Escalate: Consider ICU admission<br/>Continuous monitoring"]:::urgent ``` ### Benzodiazepine Dosing in Delirium Tremens | Feature | Details | |---------|----------| | **Severity** | Delirium tremens = life-threatening; requires aggressive dosing | | **Lorazepam dose** | 4 mg IV, repeat every 2–3 minutes until patient is calm, oriented, and seizure threshold is raised | | **Total dose** | Often 20–60 mg in first 24 hours (much higher than uncomplicated withdrawal) | | **Maintenance** | 1–2 mg every 4–6 hours after acute phase controlled | | **Monitoring** | Continuous pulse oximetry, cardiac monitoring, frequent neuro checks | **High-Yield:** Benzodiazepines raise the seizure threshold and reduce mortality in DTs. Phenytoin does NOT prevent alcohol withdrawal seizures and is NOT first-line. ### Concurrent Essential Interventions 1. **Thiamine 100 mg IV daily × 3 days** — prevents Wernicke encephalopathy (confusion, ophthalmoplegia, ataxia) 2. **Correct electrolytes** — hypokalemia, hypomagnesemia, and hypophosphatemia worsen seizure risk and arrhythmias 3. **Glucose monitoring** — hypoglycemia can mimic or worsen withdrawal symptoms 4. **ICU admission** — continuous monitoring for seizures, arrhythmias, aspiration **Clinical Pearl:** Fever in DTs is due to hypermetabolism and autonomic dysregulation, not infection. However, rule out concurrent infection (pneumonia, UTI) if fever persists. ## Why Other Options Are Incorrect **Phenytoin** (option 2) does NOT prevent alcohol withdrawal seizures. Alcohol withdrawal seizures are due to GABA-A receptor downregulation and glutamate hyperactivity — mechanisms not addressed by phenytoin. Benzodiazepines are the only proven seizure prophylaxis. **CT head and EEG** (option 3) are not the immediate next step. While imaging may be considered if seizures occur or consciousness does not improve with benzodiazepines, acute management takes priority. DTs is a clinical diagnosis. **Acamprosate** (option 4) is a long-term relapse-prevention agent for alcohol use disorder, used AFTER detoxification. It has no role in acute delirium tremens and will not prevent seizures or manage acute symptoms. [cite:Harrison 21e Ch 422; DSM-5 Alcohol Withdrawal Delirium]